A case analysis of medication adjustments on a moyamoya disease patient with endometriosis by DAPT treatment during perioperative period and formulation of DIE postoperative recurrence prevention
10.12092/j.issn.1009-2501.2024.05.003
- VernacularTitle:1例烟雾病合并子宫内膜异位症患者围手术期抗血小板药物调整及术后预防内异症复发药物选择的病例分析
- Author:
Liting LUO
1
;
Jing JIN
Author Information
1. 复旦大学附属妇产科医院药学部,上海 200090;珠海市妇幼保健院药学部,珠海 519000,广东
- Keywords:
moyamoya disease;
endometriosis;
DAPT;
preventing recurrence
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2024;29(5):495-500
- CountryChina
- Language:Chinese
-
Abstract:
AIM:To explore the key points of per-sonalized treatment and medication monitoring by clinical pharmacists in the perioperative period of moyamoya disease patients with endometriosis.METHODS:This study showed a moyamoya disease patient with endometriosis who accepting dual an-tiplatelet therapy and how to adjust medication during the perioperative period.Besides,monitor-ing the use proton pump inhibitors in the perioper-ative period and the formulating a plan of DIE post-operative recurrence prevention are also our objec-tives.RESULTS:Through individualized assessment of the patient,a personalized medication adjust-ments for dual antiplatelet therapy was deter-mined.Individualized perioperative proton pump inhibitor regimen and postoperative prevention plan for endometriosis recurrence were developed.CONCLUSION:The development of individualized medication regimens and medication monitoring is the breakthrough point for clinical pharmacists to carry out pharmaceutical services.
